Channels
Special Offers & Promotions
« Tuesday, 19 November 2013 »
- 5th Annual Next Generation Sequencing Congress 2013 - (18/11/2013 10:00 - 19/11/2013 18:00)
Over two days, the 5th Annual Next Generation Sequencing Congress will attract over 400 experts from both academia and pharma senior practitioners, working in all aspects of next generation sequencing including Personalised Healthcare / Clinical / Diagnostic Development, Genomics, Epigenetics, DNA Methylation, RNA profiling, Data management & Analysis, Human metagenomics, Single Cell Genomics and Transcriptomics from Europe and America. - Pharma IT Asia Congress 2013 - (19/11/2013 10:00 - 20/11/2013 18:00)
- Clinical Trials in CNS - (18/11/2013 10:00 - 19/11/2013 18:00)
The highly anticipated and respected 12th annual Clinical Trials in CNS Conference returns to London with a two day content packed agenda featuring new approaches taken in this field towards a number of neurodegenerative disorders, from clinical trial modelling and simulation to the role of biomarkers, the agenda presents a detailed look into many aspects of drug discovery and delivery of CNS therapeutics. This innovative conference will give delegates an opportunity to gain insights through case studies and interactive discussion into the best practices in clinical trials. - Single Cell Analysis Congress - (18/11/2013 10:00 - 19/11/2013 18:00)
As the only conference to bring together all the experts in the field of single cell analysis, attracting over 400 senior decision markers from Europe and the US, this exciting and important meeting is a must attend event. - Cell Based Assays - (18/11/2013 10:00 - 19/11/2013 18:00)
Following on from our hugely successful Cell-Based Assays conference in 2012, this year's agenda will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet. Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years.
Media Partners